Trial Profile

F9 Genotype and pharmacokinetics (PK) Hemophilia B International Study

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 10 Mar 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Nonacog alfa (Primary)
Indications Haemophilia B
Focus Pharmacodynamics; Pharmacokinetics
Acronyms GePKHIS

Most Recent Events

10 Mar 2022 Status changed from recruiting to discontinued.
08 Oct 2021 Results (n=30) of a PK analysis assessing HB mutational patterns and phenotypes associated to recurrent substitutions at FIX activation sites; using plasma samples enrolled in this trial published in the Journal of Thrombosis and Haemostasis
26 Mar 2018 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com